Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol

Demirkan S.Gündüz Ö.Devrim T.2020-06-252020-06-25201723525126https://doi.org/10.1016/j.jdcr.2017.03.017https://hdl.handle.net/20.500.12587/2546[No abstract available]eninfo:eu-repo/semantics/openAccesscalcipotriolhand-foot syndromehepatitishepatocellular carcinomasorafenibsorafenib-associated hand-foot syndrometreatmentSorafenib-asssociated hand-foot syndrome treated with topical calcipotriolArticle3435435710.1016/j.jdcr.2017.03.0172-s2.0-85024862350Q3